Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis
Annals of Cardiac Anaesthesia · 2025-10 · 28 (4) · 364-378
DOI: 10.4103/aca.aca_271_24 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of Cardiac Anaesthesia, online erschienen am 05.08.2025. Verfasst von Thomas Kavanagh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Anaesthetic Department, Royal Sussex County Hospital, University Hospitals Sussex, United Kingdom. Hauptthemen laut MEDLINE: Milrinone, Hypertension, Pulmonary, Cardiac Surgical Procedures, Vasodilator Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
To summarize the evidence on the hemodynamic effects and vasopressor requirements of adult patients with known pulmonary hypertension (PH) undergoing cardiac surgery treated with intravenous and inhaled milrinone. A total of 400 patients in 5 prospective (4 RCT) studies were included for pooled analysis. There was no significant difference in the primary outcome; mean pulmonary artery pressure (MPAP) between groups (MD: -4.80, 95% CI -10.57 to 0.98). Inhaled milrinone was associated with a greater systemic vascular resistance index (SVRI) (MD: 259.21, 95% CI 168.70 to 349.72) and reduction in pulmonary capillary wedge pressure (MD: -4.64, 95% CI -5.47 to -3.81). There were no observable differences in mean arterial pressure, pulmonary vascular resistance, cardiac index, or central venous pressure. All studies included were assessed to be moderate/some concern risk of bias. Inhaled milrinone has not been shown to have a significant beneficial effect on MPAP and SVR when compared to intravenous milrinone in patients with known PH undergoing cardiac surgery. However, it has shown some benefits in maintaining MAP and improving oxygenation in this patient cohort. The study is limited by the bias of the included studies and the variability of inhaled drug dosage and administration timing, further well-powered randomized controlled trials are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anaesthetic Department, Royal Sussex County Hospital, University Hospitals Sussex, United Kingdom.
- Department of Cardiothoracic Anesthesia and the Cardiovascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
- Anaesthetic Department, Conquest Hospital, East Sussex Healthcare Trust, United Kingdom.
Zitieren
APA
Kavanagh, T., Kilpatrick, T., Hardy, B., Lee, S., Seavill, M., Lau, C. M., Bullard, S., Green, S., & Cadd, M. (2025). Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis. Annals of Cardiac Anaesthesia, 28(4), 364-378. https://doi.org/10.4103/aca.aca_271_24
Vancouver
Kavanagh T, Kilpatrick T, Hardy B, Lee S, Seavill M, Lau CM, et al. Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis. Annals of Cardiac Anaesthesia. 2025;28(4):364-378. doi:10.4103/aca.aca_271_24
BibTeX
@article{Kavanagh2025,
author = {Kavanagh, Thomas and Kilpatrick, Thomas and Hardy, Ben and Lee, Sang and Seavill, Miles and Lau, Chun-Wun M and Bullard, Sam and Green, Samira and Cadd, Matthew},
title = {Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis},
journal = {Annals of Cardiac Anaesthesia},
year = {2025},
volume = {28},
number = {4},
pages = {364--378},
doi = {10.4103/aca.aca_271_24}
}
EUVIMED